Ahhh good. So they can plug the tooth up and not worry about a new bacterial build up under the filling. I wonder what the incidence of this is? Let's find out the costs associated with this...
To quote an article:
http://www.dent-news.com/newsdetail.asp?id=759
"Oral care experts Gary Jernberg and Richard Simonsen will fund and manage their development of the Australian biotechnology company's anti-bacterials on dental devices and materials worth about $400 million a year."
and
""The products could be launched within the next few years and could potentially have a market worth of half billion (dollars)," - Michael Oredsson (ex-CEO)
ALSO IMO - These are laboratory trials. The compounds have so far struggled to maintain efficacy within the human body - take contact lenses and catheters as examples. This was due to at least in contact lenses, a buildup of protein from the natural tear film disrupting the compounds effectiveness.
HOWEVER - because the filling will be "sealed" inside the tooth, and it's aiming at preventing decay within a solid tooth environment (not the surrounding tissue) and won't be interacting with fluids etc, I personally expect it to maintain efficacy within the body during trials in peoples mouths. Time will tell. Can't get much better results at this stage though!!
BOS Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held